User menu

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

Bibliographic reference Zhu, Andrew X ; Borger, Darrell R ; Kim, Yuhree ; Cosgrove, David ; Ejaz, Aslam ; et. al. Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. In: Annals of Surgical Oncology, Vol. 21, no. 12, p. 3827-3834 (2014)
Permanent URL http://hdl.handle.net/2078.1/151764
  1. Shaib Yasser H, Davila Jessica A, McGlynn Kathryn, El-Serag Hashem B, Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?, 10.1016/j.jhep.2003.11.030
  2. Poultsides George A., Zhu Andrew X., Choti Michael A., Pawlik Timothy M., Intrahepatic Cholangiocarcinoma, 10.1016/j.suc.2010.04.011
  3. Valle Juan, Wasan Harpreet, Palmer Daniel H., Cunningham David, Anthoney Alan, Maraveyas Anthony, Madhusudan Srinivasan, Iveson Tim, Hughes Sharon, Pereira Stephen P., Roughton Michael, Bridgewater John, Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer, 10.1056/nejmoa0908721
  4. Hezel Aram F., Deshpande Vikram, Zhu Andrew X., Genetics of Biliary Tract Cancers and Emerging Targeted Therapies, 10.1200/jco.2009.27.4787
  5. Sia D, Tovar V, Moeini A, Llovet J M, Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies, 10.1038/onc.2012.617
  6. Borger D. R., Tanabe K. K., Fan K. C., Lopez H. U., Fantin V. R., Straley K. S., Schenkein D. P., Hezel A. F., Ancukiewicz M., Liebman H. M., Kwak E. L., Clark J. W., Ryan D. P., Deshpande V., Dias-Santagata D., Ellisen L. W., Zhu A. X., Iafrate A. J., Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping, 10.1634/theoncologist.2011-0386
  7. Tannapfel Andrea, Sommerer Florian, Benicke Markus, Weinans Lars, Katalinic Alexander, Geißler Felix, Uhlmann Dirk, Hauss Johann, Wittekind Christian, Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma : INK4a-ARF alterations in cholangiocarcinoma, 10.1002/path.1139
  8. Voss Jesse S., Holtegaard Leonard M., Kerr Sarah E., Fritcher Emily G. Barr, Roberts Lewis R., Gores Gregory J., Zhang Jun, Highsmith W. Edward, Halling Kevin C., Kipp Benjamin R., Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions, 10.1016/j.humpath.2012.11.006
  9. Xu Rui Feng, Sun Ji Ping, Zhang Shi Rong, Zhu Guan Shan, Li Li Bo, Liao Yu Lin, Xie Jian Ming, Liao Wang Jun, KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients, 10.1016/j.biopha.2010.06.009
  10. Jiao Yuchen, Pawlik Timothy M, Anders Robert A, Selaru Florin M, Streppel Mirte M, Lucas Donald J, Niknafs Noushin, Guthrie Violeta Beleva, Maitra Anirban, Argani Pedram, Offerhaus G Johan A, Roa Juan Carlos, Roberts Lewis R, Gores Gregory J, Popescu Irinel, Alexandrescu Sorin T, Dima Simona, Fassan Matteo, Simbolo Michele, Mafficini Andrea, Capelli Paola, Lawlor Rita T, Ruzzenente Andrea, Guglielmi Alfredo, Tortora Giampaolo, de Braud Filippo, Scarpa Aldo, Jarnagin William, Klimstra David, Karchin Rachel, Velculescu Victor E, Hruban Ralph H, Vogelstein Bert, Kinzler Kenneth W, Papadopoulos Nickolas, Wood Laura D, Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas, 10.1038/ng.2813
  11. Wang P, Dong Q, Zhang C, Kuan P-F, Liu Y, Jeck W R, Andersen J B, Jiang W, Savich G L, Tan T-X, Auman J T, Hoskins J M, Misher A D, Moser C D, Yourstone S M, Kim J W, Cibulskis K, Getz G, Hunt H V, Thorgeirsson S S, Roberts L R, Ye D, Guan K-L, Xiong Y, Qin L-X, Chiang D Y, Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas, 10.1038/onc.2012.315
  12. Andersen Jesper B., Spee Bart, Blechacz Boris R., Avital Itzhak, Komuta Mina, Barbour Andrew, Conner Elizabeth A., Gillen Matthew C., Roskams Tania, Roberts Lewis R., Factor Valentina M., Thorgeirsson Snorri S., Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors, 10.1053/j.gastro.2011.12.005
  13. Dias-Santagata Dora, Akhavanfard Sara, David Serena S., Vernovsky Kathy, Kuhlmann Georgiana, Boisvert Susan L., Stubbs Hannah, McDermott Ultan, Settleman Jeffrey, Kwak Eunice L., Clark Jeffrey W., Isakoff Steven J., Sequist Lecia V., Engelman Jeffrey A., Lynch Thomas J., Haber Daniel A., Louis David N., Ellisen Leif W., Borger Darrell R., Iafrate A. John, Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine : Tumour genotyping for personalized cancer care, 10.1002/emmm.201000070
  14. Karagkounis Georgios, Torbenson Michael S., Daniel Hubert D., Azad Nilofer S., Diaz Luis A., Donehower Ross C., Hirose Kenzo, Ahuja Nita, Pawlik Timothy M., Choti Michael A., Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases : KRAS-BRAF Mutations in Liver Metastases, 10.1002/cncr.28347
  15. Bazan V., Agnese V., Corsale S., Calò V., Valerio M. R., Latteri M. A., Vieni S., Grassi N., Cicero G., Dardanoni G., Tomasino R. M., Colucci G., Gebbia N., Russo A., Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study, 10.1093/annonc/mdi908
  16. Andreyev H J N, Norman A R, Cunningham D, Oates J, Dix B R, Iacopetta B J, Young J, Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Benamouzig R, Jullian E, Laurent-Puig P, Olschwang S, Muller O, Hoffmann I, Rabes H M, Zietz C, Troungos C, Valavanis C, Yuen S T, Ho J W C, Croke C T, O’Donoghue D P, Giaretti W, Rapallo A, Russo A, Bazan V, Tanaka M, Omura K, Azuma T, Ohkusa T, Fujimori T, Ono Y, Pauly M, Faber C, Glaesener R, Goeij A F P M de, Arends J W, Andersen S N, Lövig T, Breivik J, Gaudernack G, Clausen O P F, Angelis P De, Meling G I, Rognum T O, Smith R, Goh H-S, Font A, Rosell R, Sun X F, Zhang H, Benhattar J, Losi L, Lee J Q, Wang S T, Clarke P A, Bell S, Quirke P, Bubb V J, Piris J, Cruickshank N R, Morton D, Fox J C, Al-Mulla F, Lees N, Hall C N, Snary D, Wilkinson K, Dillon D, Costa J, Pricolo V E, Finkelstein S D, Thebo J S, Senagore A J, Halter S A, Wadler S, Malik S, Krtolica K, Urosevic N, Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study, 10.1054/bjoc.2001.1964
  17. Woo Hyun Goo, Park Eun Sung, Thorgeirsson Snorri S., Kim Yoon Jun, Exploring genomic profiles of hepatocellular carcinoma, 10.1002/mc.20691
  18. Lee Sun, Lee Hyeon Joo, Kim Jae-Hoon, Lee Hyo-Suk, Jang Ja June, Kang Gyeong Hoon, Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis, 10.1016/s0002-9440(10)63495-5
  19. Mínguez Beatriz, Tovar Victoria, Chiang Derek, Villanueva Augusto, Llovet Josep M, Pathogenesis of hepatocellular carcinoma and molecular therapies : , 10.1097/mog.0b013e32832962a1
  20. Khan S.A., Toledano M.B., Taylor-Robinson S.D., Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma, 10.1080/13651820801992641
  21. Robertson Scott, Hyder Omar, Dodson Rebecca, Nayar Suresh K., Poling Justin, Beierl Katie, Eshleman James R., Lin Ming-Tseh, Pawlik Timothy M., Anders Robert A., The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome, 10.1016/j.humpath.2013.07.026
  22. Tannapfel A, Frequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver, 10.1136/gut.47.5.721
  23. Sia Daniela, Hoshida Yujin, Villanueva Augusto, Roayaie Sasan, Ferrer Joana, Tabak Barbara, Peix Judit, Sole Manel, Tovar Victoria, Alsinet Clara, Cornella Helena, Klotzle Brandy, Fan Jian–Bing, Cotsoglou Christian, Thung Swan N., Fuster Josep, Waxman Samuel, Garcia–Valdecasas Juan Carlos, Bruix Jordi, Schwartz Myron E., Beroukhim Rameen, Mazzaferro Vincenzo, Llovet Josep M., Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes, 10.1053/j.gastro.2013.01.001
  24. Sosman Jeffrey A., Kim Kevin B., Schuchter Lynn, Gonzalez Rene, Pavlick Anna C., Weber Jeffrey S., McArthur Grant A., Hutson Thomas E., Moschos Stergios J., Flaherty Keith T., Hersey Peter, Kefford Richard, Lawrence Donald, Puzanov Igor, Lewis Karl D., Amaravadi Ravi K., Chmielowski Bartosz, Lawrence H. Jeffrey, Shyr Yu, Ye Fei, Li Jiang, Nolop Keith B., Lee Richard J., Joe Andrew K., Ribas Antoni, Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib, 10.1056/nejmoa1112302
  25. Dang Lenny, White David W., Gross Stefan, Bennett Bryson D., Bittinger Mark A., Driggers Edward M., Fantin Valeria R., Jang Hyun Gyung, Jin Shengfang, Keenan Marie C., Marks Kevin M., Prins Robert M., Ward Patrick S., Yen Katharine E., Liau Linda M., Rabinowitz Joshua D., Cantley Lewis C., Thompson Craig B., Vander Heiden Matthew G., Su Shinsan M., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, 10.1038/nature08617
  26. Ward Patrick S., Patel Jay, Wise David R., Abdel-Wahab Omar, Bennett Bryson D., Coller Hilary A., Cross Justin R., Fantin Valeria R., Hedvat Cyrus V., Perl Alexander E., Rabinowitz Joshua D., Carroll Martin, Su Shinsan M., Sharp Kim A., Levine Ross L., Thompson Craig B., The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate, 10.1016/j.ccr.2010.01.020
  27. Losman J.-A., Looper R. E., Koivunen P., Lee S., Schneider R. K., McMahon C., Cowley G. S., Root D. E., Ebert B. L., Kaelin W. G., (R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible, 10.1126/science.1231677
  28. Kipp Benjamin R., Voss Jesse S., Kerr Sarah E., Barr Fritcher Emily G., Graham Rondell P., Zhang Lizhi, Highsmith W. Edward, Zhang Jun, Roberts Lewis R., Gores Gregory J., Halling Kevin C., Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma, 10.1016/j.humpath.2011.12.007
  29. Chan-on Waraporn, Nairismägi Maarja-Liisa, Ong Choon Kiat, Lim Weng Khong, Dima Simona, Pairojkul Chawalit, Lim Kiat Hon, McPherson John R, Cutcutache Ioana, Heng Hong Lee, Ooi London, Chung Alexander, Chow Pierce, Cheow Peng Chung, Lee Ser Yee, Choo Su Pin, Tan Iain Bee Huat, Duda Dan, Nastase Anca, Myint Swe Swe, Wong Bernice Huimin, Gan Anna, Rajasegaran Vikneswari, Ng Cedric Chuan Young, Nagarajan Sanjanaa, Jusakul Apinya, Zhang Shenli, Vohra Priya, Yu Willie, Huang DaChuan, Sithithaworn Paiboon, Yongvanit Puangrat, Wongkham Sopit, Khuntikeo Narong, Bhudhisawasdi Vajaraphongsa, Popescu Irinel, Rozen Steven G, Tan Patrick, Teh Bin Tean, Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers, 10.1038/ng.2806
  30. Ong Choon Kiat, Subimerb Chutima, Pairojkul Chawalit, Wongkham Sopit, Cutcutache Ioana, Yu Willie, McPherson John R, Allen George E, Ng Cedric Chuan Young, Wong Bernice Huimin, Myint Swe Swe, Rajasegaran Vikneswari, Heng Hong Lee, Gan Anna, Zang Zhi Jiang, Wu Yingting, Wu Jeanie, Lee Ming Hui, Huang DaChuan, Ong Pauline, Chan-on Waraporn, Cao Yun, Qian Chao-Nan, Lim Kiat Hon, Ooi Aikseng, Dykema Karl, Furge Kyle, Kukongviriyapan Veerapol, Sripa Banchob, Wongkham Chaisiri, Yongvanit Puangrat, Futreal P Andrew, Bhudhisawasdi Vajarabhongsa, Rozen Steve, Tan Patrick, Teh Bin Tean, Exome sequencing of liver fluke–associated cholangiocarcinoma, 10.1038/ng.2273
  31. Wu Yi-Mi, Su Fengyun, Kalyana-Sundaram Shanker, Khazanov Nickolay, Ateeq Bushra, Cao Xuhong, Lonigro Robert J., Vats Pankaj, Wang Rui, Lin Su-Fang, Cheng Ann-Joy, Kunju Lakshmi P., Siddiqui Javed, Tomlins Scott A., Wyngaard Peter, Sadis Seth, Roychowdhury Sameek, Hussain Maha H., Feng Felix Y., Zalupski Mark M., Talpaz Moshe, Pienta Kenneth J., Rhodes Daniel R., Robinson Dan R., Chinnaiyan Arul M., Identification of Targetable FGFR Gene Fusions in Diverse Cancers, 10.1158/2159-8290.cd-13-0050
  32. Andersen Jesper B., Thorgeirsson Snorri S., Genetic profiling of intrahepatic cholangiocarcinoma : , 10.1097/mog.0b013e3283523c7e
  33. Riener Marc-Oliver, Bawohl Marion, Clavien Pierre-Alain, Jochum Wolfram, RarePIK3CA hotspot mutations in carcinomas of the biliary tract, 10.1002/gcc.20540
  34. Ross J. S., Wang K., Gay L., Al-Rohil R., Rand J. V., Jones D. M., Lee H. J., Sheehan C. E., Otto G. A., Palmer G., Yelensky R., Lipson D., Morosini D., Hawryluk M., Catenacci D. V. T., Miller V. A., Churi C., Ali S., Stephens P. J., New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing, 10.1634/theoncologist.2013-0352